Related Experiment Video
Updated: Jul 2, 2026
06:07
Modeling Stroke in Mice: Focal Cortical Lesions by Photothrombosis
Published on: May 6, 2021
Laser therapy in acute stroke treatment
1Department of Neuroscience, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0624, USA.
Summary
Near infrared light therapy (NILT) shows promise for acute stroke treatment, offering a long therapeutic window up to 24 hours. Early trials suggest NILT is effective and safe, potentially revolutionizing stroke care.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Photomedicine
Background:
- Acute stroke treatment options are limited by narrow therapeutic windows.
- Near Infrared Light Therapy (NILT) is an emerging treatment modality for stroke.
- Preclinical studies demonstrate NILT's efficacy in improving stroke outcomes.
Purpose of the Study:
- To evaluate the preliminary efficacy and safety of NILT in acute stroke patients.
- To investigate the potential of NILT as a treatment with an extended therapeutic window.
- To explore NILT's mechanisms of action for future therapeutic development.
Main Methods:
- Phase II clinical trial (NEST-1) assessing NILT in acute stroke patients.
- Analysis of preclinical animal stroke models to establish efficacy.
- Investigation into the post-ischemic therapeutic window of NILT.
Main Results:
- Preliminary efficacy and safety of NILT demonstrated in NEST-1 trial.
- NILT exhibits a significantly longer post-ischemic therapeutic window compared to existing treatments.
- Positive outcomes observed in preclinical animal stroke models.
Conclusions:
- NILT presents a promising therapeutic option for acute stroke management.
- The extended therapeutic window of NILT could revolutionize stroke treatment protocols.
- Further research, including the NEST-II trial, is needed to confirm these findings and elucidate mechanisms.
